Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Long-acting PrEP: new opportunities with some drawbacks.Published in
Lancet HIV 2023; 10(4):e213-e215PMID
36642088ae974a485f413a2113503eed53cd6c53
10.1016/S2352-3018(22)00397-6
Scopus Count
Collections
Related articles
- Preventing HIV Infection in High-Risk Adolescents Using Preexposure Prophylaxis (PrEP).
- Authors: Blackwell CW
- Issue date: 2018 Sep-Oct
- PrEP2U: delivering HIV pre-exposure prophylaxis (PrEP) in partnership from a community setting.
- Authors: Richardson D, Tweed M, Nichols K, Finn R, Nicholson S, Darking M
- Issue date: 2023 Feb
- Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation.
- Authors: Spinelli MA, Buchbinder SP
- Issue date: 2020 Jul 27
- Investing in National HIV PrEP Preparedness.
- Authors: Johnson J, Killelea A, Farrow K
- Issue date: 2023 Mar 2
- Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.
- Authors: Irie WC, Calabrese SK, Patel RR, Mayer KH, Geng EH, Marcus JL
- Issue date: 2022 Jul